HROW Harrow, Inc.

NASDAQ

$33.07

Harrow, Inc. (HROW) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -15.2% since its last earnings release on August 10, 2026.

Harrow Missed Consensus Estimates, Reaffirms

Monday, August 10, 2026 · 4:05 PM ET

3rd Quarter, Sep 2026

Thursday · 4:05 PM ET

Earnings Whisper

-

vs $0.16

Rev est $99.88M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $37.13

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Harrow, Inc.

Harrow Health, Inc. is an ophthalmic-focused healthcare company.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.